The Illinois Department of Public Health (IDPH) is an- nouncing two new COVID-19 oral antivirals, Paxlovid (Pfizer) and Molnupiravir (Merck), will be available in Illinois later this month. The antivirals are for those with mild-to-moderate COVID-19 who are at high risk for becoming severely ill, including hospitalization or death. Both antivirals will be available by prescription only and should be taken as soon as possible after being diagnosed and within five days of the be- ginning of symptoms. Paxlovid is expected to reduce the risk of hospitalizations by 89 percent and Molnupiravir by...